Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sandy Springs, GA
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Quincy, MA
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Quincy, MA
Click here to add this to my saved trials
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Laurelton, NY
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Laurelton, NY
Click here to add this to my saved trials
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
Use of Regadenoson for a Stress Echocardiogram Protocol Using Speckle Tracking Imaging
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
Use of Regadenoson for a Stress Echocardiogram Protocol Using Speckle Tracking Imaging
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Correlation Study of Imaging Data Acquired During CABG With Data Acquired in the Cath Lab
Collaborative Pilot Study to Determine the Correlation Between Intra-Operative Observations Using SPY® Near Infra-Red Imaging and Cardiac Catheterization Laboratory Physiological Assessment of Lesion Severity (PERSEUS Pilot Study)
Status: Enrolling
Updated:  12/31/1969
East Carolina Heart Institute at Vidant Medical Center
mi
from
Greenville, NC
Correlation Study of Imaging Data Acquired During CABG With Data Acquired in the Cath Lab
Collaborative Pilot Study to Determine the Correlation Between Intra-Operative Observations Using SPY® Near Infra-Red Imaging and Cardiac Catheterization Laboratory Physiological Assessment of Lesion Severity (PERSEUS Pilot Study)
Status: Enrolling
Updated: 12/31/1969
East Carolina Heart Institute at Vidant Medical Center
mi
from
Greenville, NC
Click here to add this to my saved trials
Non-invasive Computer-Aided Phenotyping of Vasculopathy
vascuCAP: Non-invasive Computer-Aided Phenotyping of Vasculopathy
Status: Enrolling
Updated:  12/31/1969
West Jefferson Medical Center
mi
from
Marrero, LA
Non-invasive Computer-Aided Phenotyping of Vasculopathy
vascuCAP: Non-invasive Computer-Aided Phenotyping of Vasculopathy
Status: Enrolling
Updated: 12/31/1969
West Jefferson Medical Center
mi
from
Marrero, LA
Click here to add this to my saved trials
Non-invasive Computer-Aided Phenotyping of Vasculopathy
vascuCAP: Non-invasive Computer-Aided Phenotyping of Vasculopathy
Status: Enrolling
Updated:  12/31/1969
LSU ILH
mi
from
New Orleans, LA
Non-invasive Computer-Aided Phenotyping of Vasculopathy
vascuCAP: Non-invasive Computer-Aided Phenotyping of Vasculopathy
Status: Enrolling
Updated: 12/31/1969
LSU ILH
mi
from
New Orleans, LA
Click here to add this to my saved trials
Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation
Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation.
Status: Enrolling
Updated:  12/31/1969
Jean Mayer Human Nutrition Research Center on Aging
mi
from
Boston, MA
Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation
Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation.
Status: Enrolling
Updated: 12/31/1969
Jean Mayer Human Nutrition Research Center on Aging
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass
Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass.
Status: Enrolling
Updated:  12/31/1969
Advocate Children's Hospital
mi
from
Oak Lawn, IL
Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass
Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass.
Status: Enrolling
Updated: 12/31/1969
Advocate Children's Hospital
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
The Gentle Cardiac Rehabilitation Study
Development of A Tai-Chi Program To Overcome Barriers To Cardiac Rehabilitation
Status: Enrolling
Updated:  12/31/1969
Miriam Hospital
mi
from
Providence, RI
The Gentle Cardiac Rehabilitation Study
Development of A Tai-Chi Program To Overcome Barriers To Cardiac Rehabilitation
Status: Enrolling
Updated: 12/31/1969
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Heart Center Research, Llc
mi
from
Huntsville, AL
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Heart Center Research, Llc
mi
from
Huntsville, AL
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Mobile Cardiology Associates
mi
from
Mobile, AL
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Mobile Cardiology Associates
mi
from
Mobile, AL
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Oconee Heart and Vascular Center at St Mary's Hospital
mi
from
Athens, GA
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Oconee Heart and Vascular Center at St Mary's Hospital
mi
from
Athens, GA
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Cardiac Center of Texas
mi
from
McKinney, TX
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Cardiac Center of Texas
mi
from
McKinney, TX
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Multicare HS Institute for Research & Innovation
mi
from
Tacoma, WA
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Multicare HS Institute for Research & Innovation
mi
from
Tacoma, WA
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Providence Health Care- St. Paul's Hospital; University of British Columbia
mi
from
Vancouver,
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Providence Health Care- St. Paul's Hospital; University of British Columbia
mi
from
Vancouver,
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Hospital
mi
from
San Jose, CA
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Hospital
mi
from
San Jose, CA
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
St. Luke's Lipid and Diabetes Research Center
mi
from
Kansas City, MO
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
St. Luke's Lipid and Diabetes Research Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Renown Heart and Vascular
mi
from
Reno, NV
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Renown Heart and Vascular
mi
from
Reno, NV
Click here to add this to my saved trials
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia
Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia (The CREDENCE Trial)
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Chandler Regional Medical Center
mi
from
Chandler, AZ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Chandler Regional Medical Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Banner Heart Hospital
mi
from
Mesa, AZ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Banner Heart Hospital
mi
from
Mesa, AZ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Arkansas Heart Hospital
mi
from
Little Rock, AR
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
John Muir Medical Center
mi
from
Concord, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
John Muir Medical Center
mi
from
Concord, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Washington Hospital
mi
from
Fremont, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Washington Hospital
mi
from
Fremont, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Scripps Memorial Hospital La Jolla
mi
from
La Jolla, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Scripps Memorial Hospital La Jolla
mi
from
La Jolla, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Good Samaritan Hospital
mi
from
Los Angeles, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Good Samaritan Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Ronald Regean UCLA Medical Center
mi
from
Los Angeles, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Ronald Regean UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
UC Davis Medical Center
mi
from
Sacramento, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Sutter Memorial Hospital
mi
from
Sacramento, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Sutter Memorial Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Stanford Hospital and Clinics
mi
from
Stanford, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Little Company Of Mary Hospital
mi
from
Torrance, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Little Company Of Mary Hospital
mi
from
Torrance, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Torrance Memorial Medical Center
mi
from
Torrance, CA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Torrance Memorial Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Medical Center of the Rockies
mi
from
Loveland, CO
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Medical Center of the Rockies
mi
from
Loveland, CO
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Memorial Regional Hospital
mi
from
Hollywood, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Memorial Regional Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Vincent's Medical Center
mi
from
Jacksonville, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Vincent's Medical Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center - Downtown
mi
from
Jacksonville, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center - Downtown
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Baptist Hospital of Miami
mi
from
Miami, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Baptist Hospital of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Palm Beach Gardens Medical Center
mi
from
Palm Beach Gardens, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Palm Beach Gardens Medical Center
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials